India Microfluidics Market By Product Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By End User (Hospitals & Diagnostic Centres, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region & Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Microfluidics Market was valued at USD 612.32 Million in 2024 and is expected to reach USD 1253.37 Million by 2030 with a CAGR of 12.88% during the forecast period. 

A branch of technology called microfluidics uses minuscule channels, typically in the tens of micrometers, to precisely control and manipulate fluids with volumes ranging from microliters to picoliters. This innovative method has emerged as a distinctive field of study, with applications across disciplines such as chemistry, biology, medicine, and the physical sciences. Microfluidics has proven to be an extremely effective technology, offering advantages such as rapid analysis, high test accuracy, and reduced drug discovery costs. Its versatility allows it to be applied in numerous healthcare contexts, further enhancing its value and impact.

One of the key drivers behind microfluidic research is the development of lab-on-chip (LOC) technologies. These technologies have the potential to revolutionize fields such as chemistry and biology, much as integrated circuits transformed computing power. By incorporating microfluidic channels and active or passive components such as valves, filters, and mixers, LOCs are essentially microsystems that can integrate full biological or chemical laboratories onto a single chip. The continuous advancements in microfluidics and the promising potential of LOC technologies are paving the way for groundbreaking discoveries and innovations in various scientific domains.

Key Market Drivers

Increasing Demand for Point-of-care Testing

The rising demand for point of care testing or POCT is a significant driver of the microfluidics market in India because rapid, near-patient diagnostics help clinicians make quicker decisions in emergency care, chronic disease management, and decentralized settings. For instance, India’s Ayushman Arogya Mandir primary-care network reported 1,76,573 centres operationalised till February 2025 and recorded 107.10 crore screenings for hypertension and 94.56 crore screenings for diabetes, demonstrating the scale at which rapid near-patient measurements are being used in routine care pathways and pushing demand for compact, high-throughput testing solutions.

Microfluidics underpins this shift by enabling miniaturized, low-sample, and tightly controlled fluid handling that improves analytic reliability in portable diagnostics and supports integration with lab-on-a-chip formats and biosensors for actionable results at the care site. In infectious disease diagnostics as well, India’s national TB programme expanded nucleic acid amplification test facilities from 5,090 in 2022 to 6,496 in 2023 and offered rapid molecular diagnostic tests at 358 per lakh population in 2023, reinforcing demand for cartridge-based molecular platforms where microscale fluid control is central to accurate testing outside conventional laboratories.

As the need for faster diagnostics rises alongside chronic disease screening and large public-health testing volumes, microfluidics-enabled POCT devices are increasingly positioned as practical tools for early detection, monitoring, and timely treatment decisions across India.

Increasing Incidences of Chronic Diseases

The escalating prevalence of chronic diseases in India, such as diabetes, heart disease, and cancer, is significantly driving the growth of the microfluidics market. As these chronic illnesses continue to affect a larger population, there is an increasing demand for advanced diagnostic and therapeutic techniques. In response to this demand, microfluidics technology has emerged as a promising solution. Its ability to rapidly and accurately analyze small volumes of fluid offers potential for early detection and effective management of chronic conditions. This, in turn, fuels its adoption in India's healthcare sector.

According to the inaugural Longitudinal Ageing Study in India (LASI) published by the Union Ministry of Family and Health Welfare on January 6, 2020, two-thirds of senior citizens in India are affected by chronic diseases. The report also highlights that approximately 23% of the elderly population (aged 60 and above) suffer from multi-morbidity, with elderly women being more prone to experiencing multiple chronic conditions. The survey's findings were based on data from over 42,000 households, encompassing more than 72,000 older adults across all states and union territories, excluding Sikkim.

Moreover, the promising future of the microfluidics market in India is further amplified by the burgeoning middle-class population and expanded healthcare coverage. As more individuals gain access to quality healthcare services, demand for innovative technologies such as microfluidics is expected to soar. The ability of microfluidics to provide precise, timely diagnostic information contributes to improved patient outcomes and greater overall healthcare efficiency. The growing prevalence of chronic diseases, coupled with the expanding middle-class population and improved healthcare coverage, is propelling the microfluidics market in India. This technology has great potential to revolutionize the diagnosis and management of chronic conditions, contributing to a healthier, more prosperous future for the country.

Faster Turn-around Time for Analysis

The hastened turn-around time for analysis is a significant driver of the microfluidics market in India. In today's fast-paced world, where time is of the essence, the need for rapid and accurate testing is more important than ever. Microfluidics technology, with its advanced capabilities, is revolutionizing healthcare and lab testing. By enabling quick, precise results in minutes, microfluidics has emerged as a game-changer, improving patient outcomes and enhancing overall healthcare efficiency.

Unlike traditional lab tests that often require hours or even days for results, microfluidics offers unparalleled speed and efficiency. This not only increases productivity in healthcare and testing labs but also reduces patient wait times, thereby improving their overall experience. The ability to achieve swift results is particularly advantageous in critical care situations, where every minute counts, enabling healthcare professionals to make timely decisions and provide prompt treatment.

The faster turn-around time offered by microfluidics is driving its widespread adoption across India's healthcare and testing labs, fueling the growth of the market. With its ability to provide accurate and rapid testing, microfluidics is transforming the way healthcare is delivered, ensuring faster diagnoses, more effective treatments, and ultimately, better patient outcomes.

Improved Portability of Devices

The boom in portable device technology is significantly driving the demand for the microfluidics market in India. Microfluidic devices, with their capabilities for miniaturization and integration, are well-suited for portable devices, making healthcare more accessible and efficient. This technology allows for cost-effective, rapid testing and diagnosing, which is a game-changer in India's vast rural areas where access to traditional lab facilities can be challenging. Moreover, the growing trend towards point-of-care diagnostics and personalized medicine further bolsters the demand for microfluidic devices. By enabling multiple tests and analyses on a single platform, microfluidics offers a versatile solution for healthcare professionals and researchers. The portability of these devices not only revolutionizes healthcare access and delivery but also propels the growth of the microfluidics market in India.

In August 2022, Dr. Ram Chepyala and Professor Siddhartha Panda from the Indian Institute of Technology, Kanpur, developed a portable microfluidic chip holder featuring multiple ports on a sliding port holder. Their design has been granted a patent in India, simplifying the process of experimenting with microfluidic chips. The patent covers the design of the chip holder with multiple ports and a sliding port holder. The device and port holder can be manufactured using various materials, ranging from basic plastics or metals to those capable of withstanding high pressure and temperature, depending on the specific application.

Furthermore, integrating microfluidics with emerging technologies such as artificial intelligence and IoT opens new possibilities for healthcare monitoring and disease management. The ability to remotely monitor patients, collect real-time data, and provide personalized treatments enhances the overall quality of care. The increasing demand for microfluidic devices, driven by portable device technology and the advantages of cost-effectiveness, rapid testing, and personalized medicine, is transforming the healthcare landscape in India. The portability and integration capabilities of microfluidics are revolutionizing healthcare access and delivery, while also fueling the growth of the microfluidics market in the country.

Download Free Sample Report

Key Market Challenges

Integration of Microfluidics Technology with Existing Workflows

The integration of Microfluidics Technology into existing workflows is causing significant disruption in the Indian microfluidics market. This cutting-edge technology offers tremendous potential for advancements in various fields, such as healthcare, biotechnology, and pharmaceuticals. However, several challenges hinder its widespread adoption.

One major obstacle is the high initial cost associated with integrating these advanced technologies into existing infrastructure. This financial barrier makes Microfluidics Technology less accessible to smaller laboratories and research institutes, limiting their ability to leverage its benefits. Additionally, mastering the use and maintenance of these technologies involves a steep learning curve, further complicating adoption.

Another critical factor is the shortage of trained professionals in microfluidics. The lack of skilled experts who can effectively use and troubleshoot these technologies slows adoption. Moreover, many institutions have standardized workflows that are resistant to change, making it challenging to incorporate new technologies such as microfluidics into their existing processes. Despite these challenges, the potential of Microfluidics Technology to revolutionize scientific research and enhance diagnostic capabilities cannot be overlooked. Addressing these obstacles through awareness, training programs, and cost-effective solutions will be crucial in promoting wider adoption and reaping the benefits of this disruptive technology in the Indian microfluidics market.

Low Adoption Due to High Prices

High prices have been a significant barrier to the widespread adoption of microfluidic technology in India. The substantial costs associated with creating, implementing, and maintaining these systems often prove prohibitive for many potential users, particularly in the healthcare sector. This is especially impactful in a country like India, where cost-efficiency is paramount due to budget constraints in numerous healthcare facilities and research institutions. The high cost has thus led to a slower pace of adoption, impeding the growth of the Indian microfluidic market and hindering the advancements and innovations that could be achieved through its use. As a result, the potential benefits and applications of microfluidics in various sectors such as medical diagnostics, drug discovery, and biochemical research have not been fully realized in the Indian context. Addressing the high costs and making microfluidic technology more accessible and affordable could unlock its immense potential and pave the way for transformative advancements in healthcare and other fields in India.

Key Market Trends

Rising Adoption of Microfluidics Technologies in Drug Delivery Systems

The rising adoption of microfluidics technologies in drug delivery systems is accelerating demand for microfluidics in India because microscale fluid control enables reproducible production of complex formulations such as nanoparticles and controlled-release systems, reduces reagent use, and supports faster screening of formulation variables by integrating multiple lab functions on a single chip. For instance, India’s large and quality-sensitive pharmaceutical manufacturing base is reflected in drug and pharmaceutical exports of 27.85 billion dollars in FY 2023 to 24 reported by the Government of India, which strengthens the incentive for companies to adopt high-precision, scalable technologies like microfluidics to improve batch consistency and development speed in advanced drug delivery workflows. For instance, the Department of Biotechnology supported innovation translation through BIRAC and has supported 1000 plus startups, entrepreneurs and SMEs as reported in its annual report, which expands the pool of India-based developers working on novel therapeutic platforms, formulation science, and lab on chip approaches that can be directly enabled by microfluidics in drug discovery and delivery.

Need For Cost-Effective Testing in Healthcare and Diagnostics

In healthcare and diagnostics, there is an ever-growing demand for cost-effective testing solutions that address the unique challenges of the Indian microfluidics market. Microfluidic technology, renowned for its exceptional accuracy and affordability, is increasingly being embraced in India for its immense potential to revolutionize medical testing. By enabling rapid, high-throughput screening of biological samples, this cutting-edge technology not only significantly reduces the cost per test but also expedites the diagnostic process, delivering timely, accurate results. This perfect blend of cost-efficiency and speed is of utmost importance in India, where access to affordable healthcare remains a critical concern. The adoption of microfluidic solutions in the Indian healthcare landscape holds the promise of transforming the way diagnostics are conducted, ultimately enhancing the overall quality and affordability of healthcare services in the country.

Segmental Insights

Product Type Insights

Based on Product Type, Microfluidic Chips have emerged as the dominant segment in the Indian microfluidics market, and this dominance is expected to persist throughout the forecast period. The extensive range of applications, including sample preparation, cell analysis, and drug delivery, has led to significant market share for microfluidic chips. The remarkable revenue growth of this market is fueled by several benefits offered by microfluidic chips, including reduced sample and reagent usage, rapid analysis, high-throughput screening, and precise fluid flow control.

The market for microfluidic sensors is projected to grow substantially during the forecast period. The increasing demand for sensors across applications, including medical diagnostics, environmental monitoring, and food testing, is a key driver of this market's expansion. The advantages of microfluidic sensors, such as high sensitivity, rapid detection, and minimal sample volume requirements, are driving demand for these devices.

Material Insights

Based on Material, PDMS have emerged as the dominating segment in the India Microfluidics Market through 2030. PDMS is a widely used polymer in the rapid prototyping of microfluidic devices, primarily favored by the academic community due to their cost-effectiveness and ease of fabrication. However, the hydrophobic nature of these polymers poses operational challenges for microchannels in aqueous solutions. To address this issue, novel PDMS surface modifications have been introduced to mitigate the impact of hydrophobicity. Moreover, polymer-based microfluidic devices have emerged as a superior alternative to glass and silicon-based counterparts. Polymer-based materials offer advantages such as affordability, durability, ease of access, and rapid fabrication compared to silicon and glass. Polymers play a crucial role in the mass production of microfluidic chips through techniques like soft lithography, casting, injection molding, and hot embossing.

Download Free Sample Report

Regional Insights

Based on Region, West India is anticipated to dominate the India Microfluidics Market during the forecast period. The western region of India, particularly Maharashtra and Gujarat, is projected to hold a dominant position in the Indian Microfluidics Market. This can be attributed to the robust presence of healthcare facilities, advanced medical infrastructure, and significant investment in biotechnology and pharmaceutical research in these areas.

Furthermore, the western region boasts a thriving ecosystem of research institutions, academic collaborations, and industry partnerships, fostering innovation and advancing microfluidics technology. The proximity to major ports and transportation hubs also contributes to the region's accessibility for import and export of microfluidic devices and components. With a rich talent pool of skilled professionals and a supportive regulatory environment, the western region of India continues to attract both domestic and international players in the microfluidics industry. This presents a promising outlook for the growth and development of the Indian microfluidics market in the coming years. 

Recent Developments

• In Jul 2025, Truenat HPV‑HR Plus as a decentralised cervical screening tool that can deliver results in under an hour with minimal infrastructure, supporting use in low-resource settings.
• In May 2025, IARC reported that a collaborative effort led to validation of affordable HPV detection tests, and highlighted this as the first validation of an HPV detection test produced in India that can detect the eight most common cancer-causing HPV types.
• In August 2024, researchers from the Institute of Nano Science and Technology (INST) in Mohali, an autonomous institute under the Department of Science and Technology, introduced an innovative droplet microfluidics technology. This approach, combined with off-chip thermal polymerization, enabled the synthesis of tunable Polyvinylidene Fluoride (PVDF) microspheres to achieve a high electroactive (EA) phase. The microspheres exhibited uniformity and monodispersity with a narrow size distribution. The high EA phase was engineered by controlling the flow rates of oil and polymer solutions within the microfluidic device, and extensive characterization confirmed the piezoelectric response of the microspheres.
• In July 2024, researchers at the Indian Institute of Technology Guwahati developed a portable, cost-effective microfluidic system that mimics soil-like conditions. This system demonstrated that optimizing nutrient flow could improve root growth and nitrogen uptake, ultimately boosting crop yields. The primary root of a germinating seed is essential for absorbing water and nutrients, serving as the plant’s anchor. During the early stages of growth, the root navigates various soil conditions, a critical period for plant survival. Nutrient supply, pH levels, soil composition, aeration, and temperature all play significant roles in influencing root development.

Key Market Players

• AQC Chem. Lab Pvt Ltd.
• Bio-Rad Laboratories India Pvt Ltd
• Abbott India Ltd
• PerkinElmer India Pvt Ltd
• Thermo Fisher Scientific India Pvt. Ltd. 

Report Scope:

In this report, the India Microfluidics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Microfluidics Market, By Product Type:

o Microfluidic Chips

o Microfluidic Sensors

o Microfluidic Pumps

o Microneedles

o Others

• India Microfluidics Market, By Material:

o Polymer

o Glass

o Silicon

o PDMS

o Other

• India Microfluidics Market, By Application:

o In Vitro diagnostics

 Point-of-Care Testing

 Clinical Diagnostics

 Environmental Testing

 Industrial Testing

 Agro Food Testing

o Pharmaceutical Research

 Lab Analytics

 Microdispensing

 Microreaction

o Drug Delivery

 Inhaler Nozzles

 Microneedles

 Micropumps

• India Microfluidics Market, By End User:

o Hospitals & Diagnostic Centres

o Academic & Research Institutes

o Pharmaceutical & Biotechnology Companies

• India Microfluidics Market, By Region:

o North India

o South India

o West India

o East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Microfluidics Market.

Available Customizations:

India Microfluidics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).